Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
Baseus PI LITE INDOOR CAMERA
ErMurazor
Updated:
Yesterday at 12:26 PM
Ad icon
Colombo
Hard Disk For Sale
mazza
Updated:
Saturday at 10:23 PM
land for sale
justasking
Updated:
Saturday at 9:32 AM
AMD AM 5 Ryzen setup
prabodhamadusanka
Updated:
Thursday at 12:56 PM
Gampaha
ACER OKW223 Wired RGB Keyboard
chint
Updated:
Thursday at 10:17 AM
Electronics
Vehicles
Property
Search
Reply to thread
Forums
General
ElaKiri Talk!
mRNA shows promise against a rare & deadly disease.
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 29730430" data-attributes="member: 562115"><p>There are severa<strong>l non-vaccine mRNA drug candidates in development & testing phases.</strong></p><p><strong></strong></p><p><strong>mRNA-3927</strong> as described here targets a rare genetic disorder, <strong>propionic acidemia,</strong> in which patients cannot process certain parts of proteins and lipids properly.</p><p></p><p><strong>BNT-141</strong> by BioNTech, targeting ovarian cancer, bile duct cancer, adenocarcinoma of the gastroesophageal junction, colorectal cancer, pancreatic cancer, gastric cancer, solid tumours;</p><p></p><p><strong>LUNARGSD3/UX053</strong> by <strong>Ultragenyx</strong>, targeting glycogen storage disorder type III, also known as Cori’s Disease;</p><p></p><p><strong>mRNA-3705</strong>, Moderna’s second candidate, for <strong>methylmalonic acidemia</strong>;</p><p></p><p><strong>OTX-2002 by Omega Therapeutics</strong> for hepatocellular carcinoma and solid tumours.</p><p></p><p>OTX-2002 is projected to have the highest revenue by 2028, regenerating $1.6bn that year. The sales of all five candidates are forecast to reach over $2bn by 2028.</p><p></p><p>These are major advances in mRNA technology. mRNA was invented in the 1960s, and by the 1970s the scientists knew how to deliver mRNA to a cell.</p><p>The first mRNA flu vaccine was tested on mice in the 1990s. The first mRNA antirabies vaccine was tested on humans in 2013. The mRNA Ebola vaccine was selectively tested in Africa.</p><p>Finally it's the Wuhan virus that really kicked the mRNA devlopment to the current state.</p><p>(I had written before on the mRNA development in the Covid Megathreads)</p><p></p><p>In simple terms mRNA can <strong>teach the body</strong> how to make a specific protein that helps your immune system to prevent or treat disease conditions.</p></blockquote><p></p>
[QUOTE="imhotep, post: 29730430, member: 562115"] There are severa[B]l non-vaccine mRNA drug candidates in development & testing phases. mRNA-3927[/B] as described here targets a rare genetic disorder, [B]propionic acidemia,[/B] in which patients cannot process certain parts of proteins and lipids properly. [B]BNT-141[/B] by BioNTech, targeting ovarian cancer, bile duct cancer, adenocarcinoma of the gastroesophageal junction, colorectal cancer, pancreatic cancer, gastric cancer, solid tumours; [B]LUNARGSD3/UX053[/B] by [B]Ultragenyx[/B], targeting glycogen storage disorder type III, also known as Cori’s Disease; [B]mRNA-3705[/B], Moderna’s second candidate, for [B]methylmalonic acidemia[/B]; [B]OTX-2002 by Omega Therapeutics[/B] for hepatocellular carcinoma and solid tumours. OTX-2002 is projected to have the highest revenue by 2028, regenerating $1.6bn that year. The sales of all five candidates are forecast to reach over $2bn by 2028. These are major advances in mRNA technology. mRNA was invented in the 1960s, and by the 1970s the scientists knew how to deliver mRNA to a cell. The first mRNA flu vaccine was tested on mice in the 1990s. The first mRNA antirabies vaccine was tested on humans in 2013. The mRNA Ebola vaccine was selectively tested in Africa. Finally it's the Wuhan virus that really kicked the mRNA devlopment to the current state. (I had written before on the mRNA development in the Covid Megathreads) In simple terms mRNA can [B]teach the body[/B] how to make a specific protein that helps your immune system to prevent or treat disease conditions. [/QUOTE]
Insert quotes…
Verification
Hath warak paha keeyada? (hatha wadikireema paha)
Post reply
Top
Bottom